Skip to main content
Advertisement
Advertisement
BTMD
BTMD logo
Biote Corp. Class A Common Stock
1.15
USD
Sponsored
+0.08
+7.48%
Oct 26, 15:59 UTC -4
Closed
exchange

After-Market

1.15

0.00
-0.43%

Biote Corp. Class A Common Stock (BTMD) Earnings

BTMD Earnings Reports

Positive Surprise Ratio

BTMD beat 10 of 17 last estimates.

59%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$45.97M
/
-$0.02
Implied change from Q2 26 (Revenue/ EPS)
+3.93%
/
-90.48%
Implied change from Q3 25 (Revenue/ EPS)
-4.14%
/
-109.09%

Biote Corp. Class A Common Stock earnings per share and revenue

On Aug 07, 2026, BTMD reported earnings of -0.21 USD per share (EPS) for Q2 26, missing the estimate of 0.04 USD, resulting in a -614.71% surprise. Revenue reached 44.23 million, compared to an expected 45.93 million, with a -3.69% difference. The market reacted with a -27.88% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 45.97 million USD, implying an decrease of -90.48% EPS, and increase of 3.93% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Abbott Laboratories
Report Date
Oct 21, 2026 For Q3 26
Estimate
$1.42
Actual
$1.42
Surprise
-0.68%
FAQ
For Q2 2026, Biote Corp. Class A Common Stock reported EPS of -$0.21, missing estimates by -614.71%, and revenue of $44.23M, -3.69% below expectations.
The stock price moved down -27.88%, changed from $2.26 before the earnings release to $1.63 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 5 analysts, Biote Corp. Class A Common Stock is expected to report EPS of -$0.02 and revenue of $45.97M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement